Why we hide unevidenced fraud accusations and log the hiding

Why we hide unevidenced fraud accusations and log the hiding — that is the question, and I have not found it answered plainly anywhere I have looked.

I would like to talk about documentation quality as a signal, separately from product quality.

Across the certificates I have collected, the variation in what is disclosed is much larger than the variation in the purity figures. Some name the analytical procedure; some give a number and a signature.

My hypothesis is that disclosure correlates with process control, and I would like to know whether the people who audit paperwork for a living think that is naive.

Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices without justification raise different flags.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

Coming back to post #3, because the follow-up matters more than the original answer.

Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not glamorous but it is foundational.

post #4 is right about the mechanism and I think understates the practical bit.

Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you something about systems behind the document. A certificate that is a number and a signature tells you less.

Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong strength, or wrong batch on the label), and failure to provide documentation when asked.

On post #6 — agreed on the reasoning, with one qualification.

Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth documenting.

Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming implausible perfection without backing evidence is overreaching.

Picking up post #9: that is the part I would want checked first.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.

Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.